Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin Alfa for HIV-associated Sensory Neuropathy
NCT00528593Phase 2Withdrawn
- Sponsor
- Washington University School of Medicine
- Start
- Nov 2007
- Primary completion
- Oct 2009
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
A Phase 2 trial of epoetin alfa in Sensory neuropathy (SN), sponsored by Washington University School of Medicine. Planned start Nov 2007; status: withdrawn.
02
Drugs
epoetin alfa
03
Conditions
Sensory neuropathy (SN)
Beyond the preview
Go deeper on NCT00528593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00528593.